3.485
price down icon9.33%   -0.375
 
loading
前日終値:
$3.86
開ける:
$3.75
24時間の取引高:
3.70M
Relative Volume:
0.45
時価総額:
$1.04B
収益:
$6.23M
当期純損益:
$-95.90M
株価収益率:
-8.9359
EPS:
-0.39
ネットキャッシュフロー:
$-68.47M
1週間 パフォーマンス:
-7.90%
1か月 パフォーマンス:
-12.06%
6か月 パフォーマンス:
+104.67%
1年 パフォーマンス:
+278.94%
1日の値動き範囲:
Value
$3.49
$3.76
1週間の範囲:
Value
$3.49
$4.00
52週間の値動き範囲:
Value
$0.6513
$5.225

Precigen Inc Stock (PGEN) Company Profile

Name
名前
Precigen Inc
Name
セクター
Healthcare (1155)
Name
電話
301-556-9900
Name
住所
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
職員
25
Name
Twitter
@precigen
Name
次回の収益日
2025-03-19
Name
最新のSEC提出書
Name
PGEN's Discussions on Twitter

PGEN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PGEN
Precigen Inc
3.495 1.36B 6.23M -95.90M -68.47M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
381.48 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
449.22 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.46 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
710.39 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
329.13 36.23B 3.81B -644.79M -669.77M -6.24

Precigen Inc Stock (PGEN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-08-15 アップグレード JP Morgan Underweight → Neutral
2024-03-22 ダウングレード JP Morgan Neutral → Underweight
2023-05-23 開始されました JP Morgan Neutral
2022-11-18 開始されました Cantor Fitzgerald Overweight
2021-02-25 開始されました Stifel Buy
2021-02-22 開始されました Wells Fargo Overweight
2021-02-18 開始されました B. Riley Securities Buy
2020-05-08 開始されました H.C. Wainwright Buy
すべてを表示

Precigen Inc (PGEN) 最新ニュース

pulisher
01:41 AM

Precigen (NASDAQ:PGEN) Trading Down 6.1%Time to Sell? - MarketBeat

01:41 AM
pulisher
Sep 23, 2025

Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization - Yahoo Finance

Sep 23, 2025
pulisher
Sep 23, 2025

The Outlook For Precigen (NASDAQ:PGEN) - Seeking Alpha

Sep 23, 2025
pulisher
Sep 23, 2025

Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 3,596,892 Shares of Stock - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Precigen (PGEN) Is Up 7.2% After Securing $125M Credit For PAPZIMEOS Commercialization Plans Has The Bull Case Changed? - simplywall.st

Sep 23, 2025
pulisher
Sep 23, 2025

Precigen (NASDAQ:PGEN) Director Randal J. Kirk Sells 1,403,360 Shares - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Precigen, Inc. (NASDAQ:PGEN): Is Breakeven Near? - Yahoo Finance

Sep 23, 2025
pulisher
Sep 22, 2025

Precigen Bets On Gene Therapies After First FDA Approval - Finimize

Sep 22, 2025
pulisher
Sep 21, 2025

Precigen (NASDAQ:PGEN) Stock Price Up 5.2%Time to Buy? - MarketBeat

Sep 21, 2025
pulisher
Sep 20, 2025

Death Cross: How does Coherent Corp correlate with NasdaqJuly 2025 Breakouts & Real-Time Volume Spike Alerts - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Inspire Investing LLC Makes New Investment in Precigen, Inc. $PGEN - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Growth Review: What are Precigen Incs growth levers2025 EndofYear Setup & Growth Focused Investment Plans - khodrobank.com

Sep 20, 2025
pulisher
Sep 20, 2025

Precigen, Inc. (PGEN) Bolsters Financial Standing to Enhance PAPZIMEOS Commercialization - Yahoo Finance

Sep 20, 2025
pulisher
Sep 18, 2025

Investment Review: Can Precigen Inc beat the S P 5002025 EndofYear Setup & Free Community Consensus Stock Picks - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Precigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Sep 18, 2025
pulisher
Sep 18, 2025

Precigen (NASDAQ:PGEN) Stock Price Down 3.7%What's Next? - MarketBeat

Sep 18, 2025
pulisher
Sep 18, 2025

Precigen converts preferred stock into 54.9 million common shares By Investing.com - Investing.com Nigeria

Sep 18, 2025
pulisher
Sep 17, 2025

Precigen Converts Preferred Stock to Common Shares - TipRanks

Sep 17, 2025
pulisher
Sep 17, 2025

Precigen converts preferred stock into 54.9 million common shares - Investing.com India

Sep 17, 2025
pulisher
Sep 17, 2025

Pullback Watch: Can Precigen Inc scale operations efficiently2025 Winners & Losers & Community Verified Trade Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Movement Recap: Is Precigen Inc a play on infrastructure spendingRate Hike & Risk Managed Investment Signals - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Analyst Downgrade: Is Precigen Inc stock a top performer YTDTrade Ideas & Expert Approved Momentum Ideas - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment - MSN

Sep 16, 2025
pulisher
Sep 16, 2025

Growth Value: Is Precigen Inc. exposed to political riskJuly 2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Is Precigen Stock Ready For Takeoff? - StocksToTrade

Sep 16, 2025
pulisher
Sep 16, 2025

Resistance Check: Will Precigen Inc stock go up in YEARWeekly Trading Summary & Risk Adjusted Buy/Sell Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Ideas Watch: Will Precigen Inc stock go up in YEAREarnings Summary Report & Daily Market Momentum Tracking - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Precigen announces up to $125M non-dilutive financing - MSN

Sep 15, 2025
pulisher
Sep 15, 2025

Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS - Yahoo Finance

Sep 15, 2025
pulisher
Sep 14, 2025

MetLife Investment Management LLC Purchases New Position in Precigen, Inc. $PGEN - MarketBeat

Sep 14, 2025
pulisher
Sep 14, 2025

Precigen Stock Tumbles as Company Undertakes Massive Shares Sale - StocksToTrade

Sep 14, 2025
pulisher
Sep 13, 2025

Could Precigen's (PGEN) New Credit Facility Reshape Its Approach to Shareholder Dilution? - simplywall.st

Sep 13, 2025
pulisher
Sep 12, 2025

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts - MSN

Sep 12, 2025
pulisher
Sep 12, 2025

4 years from clinic to approval — Precigen’s ‘unprecedented’ FDA nod and what comes next - PharmaVoice

Sep 12, 2025
pulisher
Sep 12, 2025

EVERSANA Named by Precigen for U.S. Commercialization of PAPZIMEOS - Eastern Progress

Sep 12, 2025

Precigen Inc (PGEN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Precigen Inc (PGEN) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
KIRK RANDAL J
Director
Sep 18 '25
Sale
3.86
1,403,360
5,416,970
12,117,429
$20.38
price down icon 0.96%
$81.33
price down icon 3.26%
$28.89
price down icon 1.99%
$98.30
price down icon 1.44%
$135.81
price down icon 3.80%
biotechnology ONC
$328.85
price down icon 0.23%
大文字化:     |  ボリューム (24 時間):